# uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

> **NCT02805608** · PHASE2 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 40 (estimated)

## Conditions studied

- Urinary Bladder Neoplasms

## Interventions

- **DRUG:** Injection of 68Ga-NOTA-AE105
- **DRUG:** Injection of 18F-FDG
- **DEVICE:** Positron Emission Tomography and CT
- **DEVICE:** Positron Emission Tomography and MRI

## Key facts

- **NCT ID:** NCT02805608
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02805608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02805608, "uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02805608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*